APRIL CAR T Cells (AUTO2) Targeting BCMA and TACI for the Treatment of Multiple Myeloma
Clinical trial NCT03287804 · TERMINATED
Trial details
- NCT number
- NCT03287804
- Sponsor
- Autolus Limited
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-05
- Primary completion
- 2019-09-05
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.